| Application no. and date | 13726003.0 (espacenet) (Federated) (European Patent Register), 20130531 | | Patent/reg. no. and date | DK/EP 2854858, 20251210 | | Publication date | 20150408 | | Priority no. and date | EP 12170362, 20120531 | | EP pub. no. and date |
EP 2854858 20150408 | | Effective date | | | Applicant/owner | Laboratorios Farmacéuticos Rovi, S.A., C/ Julián Camarillo 35
28037 Madrid, ES | | Applicant ref. no. | LUPV1459223/EP-DK-GCI | | Inventor | GUTIERRO ADURIZ, Ibon, c/ Julián Camarillo 35
E-28037 Madrid, ES,
FRANCO RODRÍGUEZ, Guillermo, C/ Julián Camarillo 35
E-28037 Madrid, ES | | Representative | Dennemeyer & Associates S.A., 55, rue des Bruyères
L-1274 Howald, LU | | Opponent | | | IPC Class | A61K 47/34 (2017.01) | | Title | RISPERIDON IMPLANTATFORMULERING | | Int. application no. | EP2013061320 | | Int. publication no. | WO2013178812 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
